Click for best price
Antiulcerant Drugs Market Size, Share 2022
Antiulcerant Drugs are a variety of drugs used to treat gastric and intestinal ulcers.
This report contains market size and forecasts of Antiulcerant Drugs in Global, including the following market information:
Global Antiulcerant Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antiulcerant Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Proton Pump Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antiulcerant Drugs include Takeda Pharmaceutical, Eisai, Daewoong Pharmaceutical, Allergan, AstraZeneca plc, Valeant, Zydus and Shire, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antiulcerant Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiulcerant Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antiulcerant Drugs Market Segment Percentages, by Type, 2021 (%)
Proton Pump Inhibitors
H2 Receptor Antagonists
Gastric Mucosal Protective Drugs
Antibiotics
Antacids
Prostaglandin Agonists
Global Antiulcerant Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antiulcerant Drugs Market Segment Percentages, by Application, 2021 (%)
Mouth Ulcers
Stomach Ulcers
Leg Ulcer
Esophageal Ulcer
Bleeding Ulcer
Neuropathic Ulcers
Venous Stasis Ulcers
Arterial (Ischemic) Ulcers
Others
Global Antiulcerant Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antiulcerant Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiulcerant Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antiulcerant Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda Pharmaceutical
Eisai
Daewoong Pharmaceutical
Allergan
AstraZeneca plc
Valeant
Zydus
Shire
| Report Attributes |
Report Details |
| Report Title |
Antiulcerant Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antiulcerant Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiulcerant Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiulcerant Drugs Overall Market Size
2.1 Global Antiulcerant Drugs Market Size: 2021 VS 2028
2.2 Global Antiulcerant Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antiulcerant Drugs Players in Global Market
3.2 Top Global Antiulcerant Drugs Companies Ranked by Revenue
3.3 Global Antiulcerant Drugs Revenue by Companies
3.4 Top 3 and Top 5 Antiulcerant Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antiulcerant Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiulcerant Drugs Players in Global Market
3.6.1 List of Global Tier 1 Antiulcerant Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Antiulcerant Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Antiulcerant Drugs Market Size Markets, 2021 & 2028
4.1.2 Proton Pump Inhibitors
4.1.3 H2 Receptor Antagonists
4.1.4 Gastric Mucosal Protective Drugs
4.1.5 Antibiotics
4.1.6 Antacids
4.1.7 Prostaglandin Agonists
4.2 By Type - Global Antiulcerant Drugs Revenue & Forecasts
4.2.1 By Type - Global Antiulcerant Drugs Revenue, 2017-2022
4.2.2 By Type - Global Antiulcerant Drugs Revenue, 2023-2028
4.2.3 By Type - Global Antiulcerant Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antiulcerant Drugs Market Size, 2021 & 2028
5.1.2 Mouth Ulcers
5.1.3 Stomach Ulcers
5.1.4 Leg Ulcer
5.1.5 Esophageal Ulcer
5.1.6 Bleeding Ulcer
5.1.7 Neuropathic Ulcers
5.1.8 Venous Stasis Ulcers
5.1.9 Arterial (Ischemic) Ulcers
5.1.10 Others
5.2 By Application - Global Antiulcerant Drugs Revenue & Forecasts
5.2.1 By Application - Global Antiulcerant Drugs Revenue, 2017-2022
5.2.2 By Application - Global Antiulcerant Drugs Revenue, 2023-2028
5.2.3 By Application - Global Antiulcerant Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Antiulcerant Drugs Market Size, 2021 & 2028
6.2 By Region - Global Antiulcerant Drugs Revenue & Forecasts
6.2.1 By Region - Global Antiulcerant Drugs Revenue, 2017-2022
6.2.2 By Region - Global Antiulcerant Drugs Revenue, 2023-2028
6.2.3 By Region - Global Antiulcerant Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Antiulcerant Drugs Revenue, 2017-2028
6.3.2 US Antiulcerant Drugs Market Size, 2017-2028
6.3.3 Canada Antiulcerant Drugs Market Size, 2017-2028
6.3.4 Mexico Antiulcerant Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Antiulcerant Drugs Revenue, 2017-2028
6.4.2 Germany Antiulcerant Drugs Market Size, 2017-2028
6.4.3 France Antiulcerant Drugs Market Size, 2017-2028
6.4.4 U.K. Antiulcerant Drugs Market Size, 2017-2028
6.4.5 Italy Antiulcerant Drugs Market Size, 2017-2028
6.4.6 Russia Antiulcerant Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Antiulcerant Drugs Market Size, 2017-2028
6.4.8 Benelux Antiulcerant Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Antiulcerant Drugs Revenue, 2017-2028
6.5.2 China Antiulcerant Drugs Market Size, 2017-2028
6.5.3 Japan Antiulcerant Drugs Market Size, 2017-2028
6.5.4 South Korea Antiulcerant Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Antiulcerant Drugs Market Size, 2017-2028
6.5.6 India Antiulcerant Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Antiulcerant Drugs Revenue, 2017-2028
6.6.2 Brazil Antiulcerant Drugs Market Size, 2017-2028
6.6.3 Argentina Antiulcerant Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antiulcerant Drugs Revenue, 2017-2028
6.7.2 Turkey Antiulcerant Drugs Market Size, 2017-2028
6.7.3 Israel Antiulcerant Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Antiulcerant Drugs Market Size, 2017-2028
6.7.5 UAE Antiulcerant Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Takeda Pharmaceutical
7.1.1 Takeda Pharmaceutical Corporate Summary
7.1.2 Takeda Pharmaceutical Business Overview
7.1.3 Takeda Pharmaceutical Antiulcerant Drugs Major Product Offerings
7.1.4 Takeda Pharmaceutical Antiulcerant Drugs Revenue in Global Market (2017-2022)
7.1.5 Takeda Pharmaceutical Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Antiulcerant Drugs Major Product Offerings
7.2.4 Eisai Antiulcerant Drugs Revenue in Global Market (2017-2022)
7.2.5 Eisai Key News
7.3 Daewoong Pharmaceutical
7.3.1 Daewoong Pharmaceutical Corporate Summary
7.3.2 Daewoong Pharmaceutical Business Overview
7.3.3 Daewoong Pharmaceutical Antiulcerant Drugs Major Product Offerings
7.3.4 Daewoong Pharmaceutical Antiulcerant Drugs Revenue in Global Market (2017-2022)
7.3.5 Daewoong Pharmaceutical Key News
7.4 Allergan
7.4.1 Allergan Corporate Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan Antiulcerant Drugs Major Product Offerings
7.4.4 Allergan Antiulcerant Drugs Revenue in Global Market (2017-2022)
7.4.5 Allergan Key News
7.5 AstraZeneca plc
7.5.1 AstraZeneca plc Corporate Summary
7.5.2 AstraZeneca plc Business Overview
7.5.3 AstraZeneca plc Antiulcerant Drugs Major Product Offerings
7.5.4 AstraZeneca plc Antiulcerant Drugs Revenue in Global Market (2017-2022)
7.5.5 AstraZeneca plc Key News
7.6 Valeant
7.6.1 Valeant Corporate Summary
7.6.2 Valeant Business Overview
7.6.3 Valeant Antiulcerant Drugs Major Product Offerings
7.6.4 Valeant Antiulcerant Drugs Revenue in Global Market (2017-2022)
7.6.5 Valeant Key News
7.7 Zydus
7.7.1 Zydus Corporate Summary
7.7.2 Zydus Business Overview
7.7.3 Zydus Antiulcerant Drugs Major Product Offerings
7.7.4 Zydus Antiulcerant Drugs Revenue in Global Market (2017-2022)
7.7.5 Zydus Key News
7.8 Shire
7.8.1 Shire Corporate Summary
7.8.2 Shire Business Overview
7.8.3 Shire Antiulcerant Drugs Major Product Offerings
7.8.4 Shire Antiulcerant Drugs Revenue in Global Market (2017-2022)
7.8.5 Shire Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antiulcerant Drugs Market Opportunities & Trends in Global Market
Table 2. Antiulcerant Drugs Market Drivers in Global Market
Table 3. Antiulcerant Drugs Market Restraints in Global Market
Table 4. Key Players of Antiulcerant Drugs in Global Market
Table 5. Top Antiulcerant Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antiulcerant Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antiulcerant Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antiulcerant Drugs Product Type
Table 9. List of Global Tier 1 Antiulcerant Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiulcerant Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Antiulcerant Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antiulcerant Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antiulcerant Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Antiulcerant Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antiulcerant Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antiulcerant Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Antiulcerant Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antiulcerant Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antiulcerant Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antiulcerant Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antiulcerant Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antiulcerant Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antiulcerant Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antiulcerant Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antiulcerant Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antiulcerant Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antiulcerant Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antiulcerant Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antiulcerant Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Pharmaceutical Corporate Summary
Table 31. Takeda Pharmaceutical Antiulcerant Drugs Product Offerings
Table 32. Takeda Pharmaceutical Antiulcerant Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Antiulcerant Drugs Product Offerings
Table 35. Eisai Antiulcerant Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Daewoong Pharmaceutical Corporate Summary
Table 37. Daewoong Pharmaceutical Antiulcerant Drugs Product Offerings
Table 38. Daewoong Pharmaceutical Antiulcerant Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Allergan Corporate Summary
Table 40. Allergan Antiulcerant Drugs Product Offerings
Table 41. Allergan Antiulcerant Drugs Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca plc Corporate Summary
Table 43. AstraZeneca plc Antiulcerant Drugs Product Offerings
Table 44. AstraZeneca plc Antiulcerant Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Valeant Corporate Summary
Table 46. Valeant Antiulcerant Drugs Product Offerings
Table 47. Valeant Antiulcerant Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Zydus Corporate Summary
Table 49. Zydus Antiulcerant Drugs Product Offerings
Table 50. Zydus Antiulcerant Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Shire Corporate Summary
Table 52. Shire Antiulcerant Drugs Product Offerings
Table 53. Shire Antiulcerant Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Antiulcerant Drugs Segment by Type in 2021
Figure 2. Antiulcerant Drugs Segment by Application in 2021
Figure 3. Global Antiulcerant Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antiulcerant Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antiulcerant Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiulcerant Drugs Revenue in 2021
Figure 8. By Type - Global Antiulcerant Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antiulcerant Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antiulcerant Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antiulcerant Drugs Revenue Market Share, 2017-2028
Figure 12. US Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antiulcerant Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antiulcerant Drugs Revenue Market Share, 2017-2028
Figure 24. China Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antiulcerant Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antiulcerant Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antiulcerant Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda Pharmaceutical Antiulcerant Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Antiulcerant Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Daewoong Pharmaceutical Antiulcerant Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Allergan Antiulcerant Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca plc Antiulcerant Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Valeant Antiulcerant Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Zydus Antiulcerant Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Shire Antiulcerant Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
